Ethanol induction of FGF21 in the liver is dependent on histone acetylation and ligand activation of ChREBP by glycerol-3-phosphate

M Mi Cheong Cheong (Department of Pharmacology, University of Texas Southwestern Medical Center) B Bryan Mackowiak (Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, NIH) H Hyung Bum Kim (Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center) G Genaro Hernandez T Tulip Nandu (Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center) K Kevin Vale (Department of Pharmacology, University of Texas Southwestern Medical Center) Y Yuan Zhang L Lauren G. Zacharias (Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.) T Thomas P. Mathews (Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.) B Bin Gao (National Laboratory of Solid State Microstructures, College of Engineering and Applied Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China) W W. Lee Kraus S Steven A. Kliewer (Department of Pharmacology, University of Texas Southwestern Medical Center) D David J. Mangelsdorf (Department of Pharmacology, University of Texas Southwestern Medical Center)

Abstract

Ethanol rapidly stimulates the liver to synthesize the hormone fibroblast growth factor 21 (FGF21), which then acts on the brain to elicit a multifaceted protective response. We show that in mice, this induction of FGF21 occurs at the level of gene transcription and is regulated by two byproducts of ethanol metabolism, glycerol-3-phosphate (G3P) and acetyl-CoA. Using cell-based reporter and thermal shift binding assays, we show that G3P binds to a conserved domain and activates the transcription factor carbohydrate-responsive element-binding protein (ChREBP), which regulates the Fgf21 gene promoter. The stimulation of Fgf21 gene transcription by ethanol also requires its metabolism to acetyl-CoA and correlates with histone acetylation. Accordingly, a p300/CBP histone acetyltransferase inhibitor blocks histone acetylation, ChREBP recruitment, and transcriptional activation at the Fgf21 promoter. Together, these findings reveal a dual regulatory mechanism driven by both G3P and acetyl-CoA that explains ethanol’s robust stimulatory effect on Fgf21 and possibly other ChREBP target genes in the liver.

Article Details

Volume / Issue Vol. 122, Issue 22
Published June 03, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

M

Mi Cheong Cheong

Department of Pharmacology, University of Texas Southwestern Medical Center

B

Bryan Mackowiak

Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, NIH

H

Hyung Bum Kim

Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center

G

Genaro Hernandez

T

Tulip Nandu

Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center

K

Kevin Vale

Department of Pharmacology, University of Texas Southwestern Medical Center

Y

Yuan Zhang

L

Lauren G. Zacharias

Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.

T

Thomas P. Mathews

Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.

B

Bin Gao

National Laboratory of Solid State Microstructures, College of Engineering and Applied Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China

W

W. Lee Kraus

S

Steven A. Kliewer

Department of Pharmacology, University of Texas Southwestern Medical Center

D

David J. Mangelsdorf

Department of Pharmacology, University of Texas Southwestern Medical Center